VBI Vaccines
22 Third Street, Suite 2241
Cambridge
Massachusetts
02142
United States
Tel: 617-830-3031
Website: http://www.vbivaccines.com/
Email: info@vbivaccines.com
145 articles with VBI Vaccines
-
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares
10/26/2017
VBI also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of common shares offered in the public offering.
-
VBI Vaccines Booming in Kendall Square, Ottawa and Israel
10/9/2017
-
VBI Vaccines Reports Positive Outcome From Phase III Pre-IND Discussions With The FDA For Hepatitis B Vaccine, Sci-B-Vac
6/19/2017
-
Meet VBI Vaccines, The Biotech Up 100% In 2017
3/8/2017
-
VBI Vaccines Receives Positive Response From Health Canada’s Initial Evaluation Of The Proposed Sci-B-Vac Phase III Clinical Program
2/22/2017
-
VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac Phase III Clinical Study
2/7/2017
-
VBI Vaccines Completes Pre-IND Meeting For Its Glioblastoma Immunotherapy Candidate
10/12/2016
-
VBI Vaccines Completes Enrollment Of Participants In The Phase I Clinical Trial Of Its Preventative Cytomegalovirus Vaccine Candidate
9/20/2016
-
VBI Vaccines To Present At The World Vaccine Congress Washington
3/29/2016
-
VBI Vaccines Presents New Data Supporting Its Glioblastoma Immunotherapy Program At The Keystone Symposia Cancer Vaccines Conference
3/7/2016
-
VBI Vaccines To Present At The LD Micro Conference
11/25/2015
-
VBI Vaccines Presents Update And New Data Supporting Its Glioblastoma Immunotherapy Program At The ESMO Symposium On Immuno-Oncology
11/20/2015
-
VBI Vaccines To Present Update And New Data Supporting Its RSV And CMV Vaccine Programs At The World Vaccine Congress Europe
11/6/2015
-
VBI Vaccines And SciVac Therapeutics To Live Webcast Joint Conference Call For Shareholders To Discuss Proposed Merger
11/4/2015
-
VBI Vaccines And Scivac Therapeutics To Hold Joint Conference Call For Shareholders To Discuss Proposed Merger
10/30/2015
-
VBI Vaccines Announces Development Of A Novel Glioblastoma Immunotherapy Candidate
10/8/2015
-
VBI Vaccines To Present At The 15th Annual Biotech In Europe Forum
9/24/2015
-
VBI Vaccines Promotes Dr. David E. Anderson To Chief Scientific Officer
9/14/2015
-
VBI Vaccines Awarded NRC-IRAP Funding To Leverage Its Evlp Platform In The Development Of A Novel RSV Vaccine Candidate
9/9/2015
-
VBI Vaccines To Present At The Rodman & Renshaw 17th Annual Global Investment Conference
9/3/2015